Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Autoimmune Disease

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

J Autoimmun.

Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, Cozzi G, Depascale R, Zanatta E, Gasparotto M, Benvenuti F, Bindoli S, Gatto M, Felicetti M, Ortolan A, Campaniello D, Larosa M, Lorenzin M, Ramonda R, Sfriso P, Schiavon F, Iaccarino L, Doria A

doi: 10.1016/j.jaut.2020.102502.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Ann Rheum Dis.

Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, Isaacs JD, Mariette X, McInnes I, Mueller-Ladner U, Openshaw P, Smolen JS, Stamm TA, Wiek D, Schulze-Koops H

doi: 10.1136/annrheumdis-2020-217877.

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

J Autoimmun.

Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA, Snowden JA, Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

doi: 10.1016/j.jaut.2018.06.002.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Ann Rheum Dis.

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I

doi: 10.1136/annrheumdis-2020-217960.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice

J Eur Acad Dermatol Venereol.

Gisondi P, Piaserico S, Conti A, Naldi L

doi: 10.1111/jdv.16515.

Immune Response

Age-Related differences in immunological responses to SARS-CoV-2

J Allergy Clin Immunol Pract.

Yin Wong LS, Ling Loo EX, Hui Kang AY, Lau HX, Tambyah PA, Tham EH

doi: 10.1016/j.jaip.2020.08.026.

Immune Response

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Nature

Lucas C, Vogels CBF, Yildirim I, Rothman JE, Lu P, Monteiro V, Gelhausen JR, Campbell M, Silva J, Tabachikova A, Peña-Hernandez MA, Muenker MC, Breban MI, Fauver JR, Mohanty S, Huang J, Yale SARS-CoV-2 Genomic Surveillance Initiative., Shaw AC, Ko AI, Omer SB, Grubaugh ND, Iwasaki A

doi: 10.1038/s41586-021-04085-y

Mycophenolate Mofetil In Autoimmune Hepatitis Patients With Suboptimal Outcomes To Standard Therapy: The Tapestry Study

Roberts SK, Lim R, Strasser S, Nicoll A, Gazzola A, Mitchell J, Siow W, Khoo T, Hamarneh Z, Weltman M, Gow P, Janko N, Tse E, Mishra G, Cheng EH, Levy M, Cheng W, Sood S, Skoien R, Mitchell J, Zekry A, George J, MacQuillan G, Wigg A, Stuart K, Sievert W, McCaughan G; ALA Clinical Research Network

doi: 10.1016/j.cgh.2017.09.063.

Further Publications Immunology

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

N Engl J Med

El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J, COVE Study Group.

doi: 10.1056/NEJMoa2113017

Related content

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice

Age-Related differences in immunological responses to SARS-CoV-2

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Mycophenolate Mofetil In Autoimmune Hepatitis Patients With Suboptimal Outcomes To Standard Therapy: The Tapestry Study

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase